US Patent 7928064 Transgenically produced antithrombin III
Patent 7928064 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on April, 2011 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7928064 Transgenically produced antithrombin III
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.